Division of Biomedical Research & Development Iwate Medical University Institute for Biomedical Sciences

News

  • 2026.11.06

  • 2026.10.30

    Nishizuka gave an introduction on business plan using OTS-Probes at the 2nd breakout session, “Healthcare and Health Tech,” of the Iwate International Innovation Convention (Morioka).
  • 2026.10.22

    Kumiko Umemoto, MD, PhD, from St. Marianna University School of Medicine, Takeshi Iwaya, MD, PhD, from the Department of Clinical Oncology, Iwate Medical University, and Nishizuka gave a presentation on the research using OTS-Assay at the 64th Annual Meeting of the Japan Society of Clinical Oncology (Kobe).
  • 2026.10.17

    Nishizuka gave a talk on the research using OTS-Assay at Symposium 2 of the 30th Annual Meeting of the Japanese Society of Surgical Pathology (Tokyo).
  • 2026.10.11

    Abo gave a presentation on the research using OTS-Assay at the 88th Annual Meeting of the Japanese Society of Hematology (Kyoto).

Alteration of
an Opt-Out Choice

Last Updated : 2026.10.09

Precautions

Our patient opt-out policy permits participants to choose whether they want to use their personal information and specimens provided for our medical research. According to the policy of the Japanese Government, patients or people acting as their proxies have the right to alter the opt-out choice they made when giving informed consent for the medical research. We are currently announcing the above protocols for the opt-out opportunities. Please note, however, that we may not be able to identify individuals once their personal information and specimens provided for our medical research have been anonymously processed.